
"Sector" = median of Healthcare across 84 companies
Balsm Alofoq Medical Company is a Saudi-based medical devices company listed on the Saudi Exchange under ticker 9620. The company specializes in the distribution and sale of medical equipment, devices, and supplies to healthcare providers. Its product portfolio includes diagnostic equipment, surgical instruments, and consumables used in hospitals, clinics, and medical centers. The company operates primarily in the Kingdom of Saudi Arabia, serving the growing healthcare sector.
The company generates revenue primarily through the sale of medical devices and equipment to healthcare institutions. Its business model relies on establishing partnerships with international manufacturers to distribute their products in the Saudi market. Revenue is derived from both direct sales and service contracts, including maintenance and after-sales support. The company's gross margin of 38.24% indicates a reasonable markup on its products, while its operating margin of 13.05% reflects efficient cost management.
Balsm Alofoq operates in the medical devices industry within the healthcare sector. The Saudi medical devices market is competitive, with many local and international players. The company's small market cap of 56.80M SAR suggests it is a niche player. Its price-to-sales ratio of 2.79 and EV/EBITDA of 13.86 are moderate. The company's profit margin of 9.66% is healthy, but earnings declined sharply by 77.6% year-over-year, indicating recent challenges. The low debt of 1.51M SAR relative to cash of 10.84M SAR provides financial stability.
The company's primary customers are hospitals, clinics, and other healthcare providers in Saudi Arabia. It targets both public and private sector institutions. The geographic market is almost entirely domestic, focusing on the Saudi healthcare system, which is expanding under Vision 2030. The company's small size allows it to serve specialized needs and provide personalized service to its clients.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Cash dividends by ex-date, not an investment recommendation.
Wrqti brings Balsm Alofoq Medical Company data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Balsm Alofoq Medical Company:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Some companies may need additional data sync.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.